RCKTW vs. ATNFW, LBPSW, AARD, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, and BTMDW
Should you be buying Rocket Pharmaceuticals stock or one of its competitors? The main competitors of Rocket Pharmaceuticals include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aardvark Therapeutics (AARD), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry.
Rocket Pharmaceuticals vs.
Rocket Pharmaceuticals (NASDAQ:RCKTW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, community ranking, media sentiment, analyst recommendations, profitability and dividends.
Rocket Pharmaceuticals and 180 Life Sciences both received 0 outperform votes by MarketBeat users.
In the previous week, 180 Life Sciences had 1 more articles in the media than Rocket Pharmaceuticals. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Rocket Pharmaceuticals. 180 Life Sciences' average media sentiment score of 1.38 beat Rocket Pharmaceuticals' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media.
Summary
180 Life Sciences beats Rocket Pharmaceuticals on 2 of the 2 factors compared between the two stocks.
Get Rocket Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for RCKTW and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
RCKTW vs. The Competition
Rocket Pharmaceuticals Competitors List
Related Companies and Tools
This page (NASDAQ:RCKTW) was last updated on 2/22/2025 by MarketBeat.com Staff
Free RCKTW Stock Alerts